{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T01:34:43Z","timestamp":1790472883116,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,11,27]],"date-time":"2014-11-27T00:00:00Z","timestamp":1417046400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1007\/s10822-014-9815-2","type":"journal-article","created":{"date-parts":[[2014,12,2]],"date-time":"2014-12-02T13:28:16Z","timestamp":1417526896000},"page":"101-112","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Chemical and protein structural basis for biological crosstalk between PPAR\u03b1 and COX enzymes"],"prefix":"10.1007","volume":"29","author":[{"given":"Ann E.","family":"Cleves","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay N.","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,11,27]]},"reference":[{"issue":"10","key":"9815_CR1","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1021\/jm051139t","volume":"49","author":"AE Cleves","year":"2006","unstructured":"Cleves AE, Jain AN (2006) Robust ligand-based modeling of the biological targets of known drugs. J Med Chem 49(10):2921\u20132938","journal-title":"J Med Chem"},{"issue":"2","key":"9815_CR2","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nbt1284","volume":"25","author":"MJ Keiser","year":"2007","unstructured":"Keiser MJ, Roth BL, Armbruster BN, Ernsberger P, Irwin JJ, Shoichet BK (2007) Relating protein pharmacology by ligand chemistry. Nat Biotechnol 25(2):197\u2013206","journal-title":"Nat Biotechnol"},{"issue":"7270","key":"9815_CR3","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nature08506","volume":"462","author":"MJ Keiser","year":"2009","unstructured":"Keiser MJ, Setola V, Irwin JJ, Laggner C, Abbas AI, Hufeisen SJ, Jensen NH, Kuijer MB, Matos RC, Tran TB, Whaley R, Glennon RA, Hert J, Thomas KLH, Edwards DD, Shoicet BK, Roth BL (2009) Predicting new molecular targets for known drugs. Nature 462(7270):175\u2013181","journal-title":"Nature"},{"issue":"5","key":"9815_CR4","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/clpt.2011.177","volume":"90","author":"J Mestres","year":"2011","unstructured":"Mestres J, Seifert S, Oprea T (2011) Linking pharmacology to clinical reports: cyclobenzaprine and its possible association with serotonin syndrome. Clin Pharmacol Ther 90(5):662\u2013665","journal-title":"Clin Pharmacol Ther"},{"issue":"12","key":"9815_CR5","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1021\/cb300317y","volume":"7","author":"AA Antol\u00edn","year":"2012","unstructured":"Antol\u00edn AA, Jalencas X, Yelamos J, Mestres J (2012) Identification of pim kinases as novel targets for pj34 with confounding effects in parp biology. ACS Chem Biol 7(12):1962\u20131967","journal-title":"ACS Chem Biol"},{"issue":"6","key":"9815_CR6","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s10822-009-9266-3","volume":"23","author":"AN Jain","year":"2009","unstructured":"Jain AN (2009) Effects of protein conformation in docking: improved pose prediction through protein pocket adaptation. J Comput Aided Mol Des 23(6):355\u2013374","journal-title":"J Comput Aided Mol Des"},{"issue":"9","key":"9815_CR7","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1002\/prot.23103","volume":"79","author":"R Spitzer","year":"2013","unstructured":"Spitzer R, Cleves AE, Varela R, Jain AN (2013) Protein function annotation by local binding site surface similarity. Proteins 79(9):2746\u201363","journal-title":"Proteins"},{"issue":"19","key":"9815_CR8","doi-asserted-by":"crossref","first-page":"6771","DOI":"10.1021\/jm200666a","volume":"54","author":"ER Yera","year":"2011","unstructured":"Yera ER, Cleves AE, Jain AN (2011) Chemical structural novelty: on-targets and off-targets. J Med Chem 54(19):6771\u20136785","journal-title":"J Med Chem"},{"key":"9815_CR9","first-page":"160","volume":"19","author":"ER Yera","year":"2014","unstructured":"Yera ER, Cleves AE, Jain AN (2014) Prediction of off-target drug effects through data fusion. Pac Symp Biocomput 19:160\u2013171","journal-title":"Pac Symp Biocomput"},{"issue":"9","key":"9815_CR10","doi-asserted-by":"crossref","first-page":"5452","DOI":"10.1074\/jbc.M707834200","volume":"283","author":"RA Domaoal","year":"2008","unstructured":"Domaoal RA, McMahon M, Thio CL, Bailey CM, Tirado-Rives J, Obikhod A, Detorio M, Rapp KL, Siliciano RF, Schinazi RF, Anderson KS (2008) Pre-steady-state kinetic studies establish entecavir 5\u2032-triphosphate as a substrate for HIV-1 reverse transcriptase. J Biol Chem 283(9):5452\u20135459","journal-title":"J Biol Chem"},{"issue":"6","key":"9815_CR11","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1128\/AAC.01703-09","volume":"54","author":"K Lin","year":"2010","unstructured":"Lin K, Karwowska S, Lam E, Limoli K, Evans TG, Avila C (2010) Telbivudine exhibits no inhibitory activity against HIV-1 clinical isolates in vitro. Antimicrob Agents Chemother 54(6):2670\u20132673","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"9815_CR12","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0026-895X(25)09567-7","volume":"38","author":"R Fernandez-Larsson","year":"1990","unstructured":"Fernandez-Larsson R, Patterson JL (1990) Ribavirin is an inhibitor of human immunodeficiency virus reverse transcriptase. Mol Pharmacol 38(6):766\u2013770","journal-title":"Mol Pharmacol"},{"issue":"18","key":"9815_CR13","doi-asserted-by":"crossref","first-page":"9301","DOI":"10.1128\/JVI.01006-10","volume":"84","author":"CL Clouser","year":"2010","unstructured":"Clouser CL, Patterson SE, Mansky LM (2010) Exploiting drug repositioning for discovery of a novel hiv combination therapy. J Virol 84(18):9301\u20139309","journal-title":"J Virol"},{"issue":"3","key":"9815_CR14","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.chom.2008.07.008","volume":"4","author":"A Lisco","year":"2008","unstructured":"Lisco A, Vanpouille C, Tchesnokov EP, Grivel JC, Biancotto A, Brichacek B, Elliott J, Fromentin E, Shattock R, Anton P, Gorelick R, Balzarini J, McGuigan C, Derudas M, Gotte M, Schinazi RF, Margolis L (2008) Acyclovir is activated into a HIV-1 reverse transcriptase inhibitor in herpesvirus-infected human tissues. Cell Host Microbe 4(3):260\u2013270","journal-title":"Cell Host Microbe"},{"issue":"10","key":"9815_CR15","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/nrc1951","volume":"6","author":"RH Shoemaker","year":"2006","unstructured":"Shoemaker RH (2006) The nci60 human tumour cell line anticancer drug screen. Nat Rev Cancer 6(10):813\u2013823","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"9815_CR16","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S1570-0232(03)00500-2","volume":"794","author":"L Du","year":"2003","unstructured":"Du L, Xu Y, Musson DG (2003) Simultaneous determination of clofibrate and its active metabolite clofibric acid in human plasma by reversed-phase high-performance liquid chromatography with ultraviolet absorbance detection. J Chromatogr B 794(2):343\u2013351","journal-title":"J Chromatogr B"},{"issue":"1","key":"9815_CR17","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2165\/00003495-200767010-00013","volume":"67","author":"GM Keating","year":"2007","unstructured":"Keating GM, Croom KF (2007) Fenofibrate. Drugs 67(1):121\u2013153","journal-title":"Drugs"},{"issue":"6","key":"9815_CR18","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s10822-011-9533-y","volume":"26","author":"R Spitzer","year":"2012","unstructured":"Spitzer R, Jain AN (2012) Surflex-dock: docking benchmarks and real-world application. J Comput Aided Mol Des 26(6):687\u2013699","journal-title":"J Comput Aided Mol Des"},{"issue":"1","key":"9815_CR19","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev.biochem.69.1.145","volume":"69","author":"WL Smith","year":"2000","unstructured":"Smith WL, DeWitt DL, Garavito RM (2000) Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem 69(1):145\u2013182","journal-title":"Annu Rev Biochem"},{"issue":"6610","key":"9815_CR20","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/384644a0","volume":"384","author":"RG Kurumbail","year":"1996","unstructured":"Kurumbail RG, Stevens AM, Gierse JK, McDonald JJ, Stegeman RA, Pak JY, Gildehaus D, Miyashiro JM, Penning TD, Seibert K, Isakson PC, Stallings WC (1996) Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents. Nature 384(6610):644\u2013648","journal-title":"Nature"},{"issue":"9","key":"9815_CR21","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1002\/prot.23103","volume":"79","author":"R Spitzer","year":"2011","unstructured":"Spitzer R, Cleves AE, Jain AN (2011) Surface-based protein binding pocket similarity. Proteins 79(9):2746\u20132763","journal-title":"Proteins"},{"issue":"7","key":"9815_CR22","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1093\/nar\/gki524","volume":"33","author":"Y Zhang","year":"2005","unstructured":"Zhang Y, Skolnick J (2005) Tm-align: a protein structure alignment algorithm based on the TM-score. Nucleic Acids Res 33(7):2302\u20132309","journal-title":"Nucleic Acids Res"},{"key":"9815_CR23","doi-asserted-by":"crossref","unstructured":"Xu HE, Lambert MH, Montana VG, Plunket KD, Moore LB, Collins JL, Oplinger JA, Kliewer SA, Gampe RT, McKee DD, Moore JT, Willson Timothy M (2001) Structural determinants of ligand binding selectivity between the peroxisome proliferator-activated receptors. Proc Natl Acad Sci 98(24):13919\u201313924","DOI":"10.1073\/pnas.241410198"},{"issue":"5","key":"9815_CR24","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/cmdc.200600307","volume":"2","author":"G Fracchiolla","year":"2007","unstructured":"Fracchiolla G, Laghezza A, Piemontese L, Carbonara G, Lavecchia A, Tortorella P, Crestani M, Novellino E, Loiodice F (2007) Synthesis, biological evaluation, and molecular modeling investigation of chiral phenoxyacetic acid analogues with ppar $$\\alpha$$ \u03b1 and ppar $$\\gamma$$ \u03b3 agonist activity. ChemMedChem 2(5):641\u2013654","journal-title":"ChemMedChem"},{"issue":"7","key":"9815_CR25","doi-asserted-by":"crossref","first-page":"819","DOI":"10.2174\/156802611795165106","volume":"11","author":"F Loiodice","year":"2011","unstructured":"Loiodice F, Pochetti G (2011) Structural insight into the crucial role of ligand chirality in the activation of ppars by crystallographic methods. Curr Top Med Chem 11(7):819\u2013839","journal-title":"Curr Top Med Chem"},{"issue":"4","key":"9815_CR26","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/cbdd.12102","volume":"81","author":"S Hidalgo-Figueroa","year":"2013","unstructured":"Hidalgo-Figueroa S, Ram\u00edrez-Espinosa JJ, Estrada-Soto S, Almanza-P\u00e9rez JC, Rom\u00e1n-Ramos R, Alarc\u00f3n-Aguilar FJ, Hern\u00e1ndez-Rosado JV, Moreno-D\u00edaz H, D\u00edaz-Couti\u00f1o D, Navarrete-V\u00e1zquez G (2013) Discovery of thiazolidine-2, 4-dione\/biphenylcarbonitrile hybrid as dual ppar $$\\alpha \/\\gamma$$ \u03b1 \/ \u03b3 modulator with antidiabetic effect: in vitro, in silico and in vivo approaches. Chem Biol Drug Des 81(4):474\u2013483","journal-title":"Chem Biol Drug Des"},{"issue":"1","key":"9815_CR27","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0014-2999(95)00302-2","volume":"281","author":"K Glaser","year":"1995","unstructured":"Glaser K, Sung ML, O\u2019Neill K, Hartman D, Carlson R, Kreft A, Kubrak D, Hsiao CL, Weichman B (1995) Etodolac selectively inhibits human prostaglandin G\/H synthase 2 (PGHS-2) versus human PGHS-1. Eur J Pharmacol 281(1):107\u2013111","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"9815_CR28","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1067\/mcp.2000.108507","volume":"68","author":"JT Backman","year":"2000","unstructured":"Backman JT, Kyrklund C, Kivist\u00f6 KT, Wang JS, Neuvonen PJ (2000) Plasma concentrations of active simvastatin acid are increased by gemfibrozil. Clin Pharmacol Ther 68(2):122\u2013129","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"9815_CR29","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/cpt1978244432","volume":"24","author":"R Gugler","year":"1978","unstructured":"Gugler R, Hartlapp J (1978) Clofibrate kinetics after single and multiple doses. Clin Pharmacol Ther 24(4):432\u2013438","journal-title":"Clin Pharmacol Ther"},{"issue":"12","key":"9815_CR30","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1194\/jlr.M800358-JLR200","volume":"49","author":"HW Bai","year":"2008","unstructured":"Bai HW, Zhu BT (2008) Strong activation of cyclooxygenase I and II catalytic activity by dietary bioflavonoids. J Lipid Res 49(12):2557\u20132570","journal-title":"J Lipid Res"},{"issue":"9","key":"9815_CR31","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1139\/y97-130","volume":"75","author":"D Riendeau","year":"1997","unstructured":"Riendeau D, Charleson S, Cromlish W, Mancini JA, Wong E, Guay J (1997) Comparison of the cyclooxygenase-1 inhibitory properties of nonsteroidal anti-inflammatory drugs and selective cox-2 inhibitors, using sensitive microsomal and platelet assays. Can J Physiol Pharmacol 75(9):1088\u20131095","journal-title":"Can J Physiol Pharmacol"},{"key":"9815_CR32","doi-asserted-by":"crossref","unstructured":"Chandrasekharan N, Dai H, Roos KLT, Evanson NK, Tomsik J, Elton TS, Simmons DL (2002) Cox-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic\/antipyretic drugs: cloning, structure, and expression. Proc Natl Acad Sci 99(21):13926\u201313931","DOI":"10.1073\/pnas.162468699"},{"issue":"19","key":"9815_CR33","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1161\/01.CIR.98.19.2088","volume":"98","author":"B Staels","year":"1998","unstructured":"Staels B, Dallongeville J, Auwerx J, Schoonjans K, Leitersdorf E, Fruchart JC (1998) Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation 98(19):2088\u20132093","journal-title":"Circulation"},{"issue":"12","key":"9815_CR34","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1001\/jama.2011.353","volume":"305","author":"CA Jackevicius","year":"2011","unstructured":"Jackevicius CA, Tu JV, Ross JS, Ko DT, Carreon D, Krumholz HM (2011) Use of fibrates in the united states and canada. JAMA 305(12):1217\u20131224","journal-title":"JAMA"},{"issue":"6116","key":"9815_CR35","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1126\/science.1230719","volume":"339","author":"FK Swirski","year":"2013","unstructured":"Swirski FK, Nahrendorf M (2013) Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure. Science 339(6116):161\u2013166","journal-title":"Science"},{"key":"9815_CR36","doi-asserted-by":"crossref","unstructured":"Rakhshandehroo M, Knoch B, M\u00fcller M, Kersten S (2010) Peroxisome proliferator-activated receptor alpha target genes. PPAR research 2010. doi: 10.1155\/2010\/612089","DOI":"10.1155\/2010\/612089"},{"issue":"6662","key":"9815_CR37","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/34184","volume":"391","author":"C Jiang","year":"1998","unstructured":"Jiang C, Ting AT, Seed B (1998) Ppar- $$\\gamma$$ \u03b3 agonists inhibit production of monocyte inflammatory cytokines. Nature 391(6662):82\u201386","journal-title":"Nature"},{"issue":"3","key":"9815_CR38","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1677\/joe.0.1690453","volume":"169","author":"P Delerive","year":"2001","unstructured":"Delerive P, Fruchart JC, Staels B (2001) Peroxisome proliferator-activated receptors in inflammation control. J Endocrinol 169(3):453\u2013459","journal-title":"J Endocrinol"},{"issue":"10","key":"9815_CR39","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/nri912","volume":"2","author":"RA Daynes","year":"2002","unstructured":"Daynes RA, Jones DC (2002) Emerging roles of ppars in inflammation and immunity. Nat Rev Immunol 2(10):748\u2013759","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"9815_CR40","first-page":"345","volume":"36","author":"A Madej","year":"1998","unstructured":"Madej A, Okopien B, Kowalski J, Zielinski M, Wysocki J, Szygula B, Kalina Z, Herman Z (1998) Effects of fenofibrate on plasma cytokine concentrations in patients with atherosclerosis and hyperlipoproteinemia iib. Int J Clin Pharmacol Ther 36(6):345","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"8","key":"9815_CR41","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1128\/AAC.00219-07","volume":"51","author":"A Budd","year":"2007","unstructured":"Budd A, Alleva L, Alsharifi M, Koskinen A, Smythe V, M\u00fcllbacher A, Wood J, Clark I (2007) Increased survival after gemfibrozil treatment of severe mouse influenza. Antimicrob Agents Chemother 51(8):2965\u20132968","journal-title":"Antimicrob Agents Chemother"},{"issue":"6687","key":"9815_CR42","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/31701","volume":"393","author":"B Staels","year":"1998","unstructured":"Staels B, Koenig W, Habib A, Merval R, Lebret M, Torra IP, Delerive P, Fadel A, Chinetti G, Fruchart JC, Najib J, Maclouf J, Tedgui A (1998) Activation of human aortic smooth-muscle cells is inhibited by ppar $$\\alpha$$ \u03b1 but not by ppar $$\\alpha$$ \u03b1 activators. Nature 393(6687):790\u2013793","journal-title":"Nature"},{"issue":"1","key":"9815_CR43","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0006-291X(77)80180-0","volume":"77","author":"IH Williams","year":"1977","unstructured":"Williams IH, Efthimios Polakis S (1977) Differentiation of 3t3-l1 fibroblasts to adipocytes the effect of indomethacin, prostaglandin E1 and cyclic amp on the process of differentiation. Biochem Biophys Res Commun 77(1):175\u2013186","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"9815_CR44","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1074\/jbc.272.6.3406","volume":"272","author":"JM Lehmann","year":"1997","unstructured":"Lehmann JM, Lenhard JM, Oliver BB, Ringold GM, Kliewer SA (1997) Peroxisome proliferator-activated receptors $$\\alpha$$ \u03b1 and $$\\gamma$$ \u03b3 are activated by indomethacin and other non-steroidal anti-inflammatory drugs. J Biol Chem 272(6):3406\u20133410","journal-title":"J Biol Chem"},{"issue":"4","key":"9815_CR45","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.ejps.2012.12.029","volume":"48","author":"JR Santin","year":"2013","unstructured":"Santin JR, Uchoa FD, Lima MdCA, Rabello MM, Machado ID, Hernandes MZ, Amato AA, Milton FA, Webb P, Neves FdAR, Galdino SL, Pitta IR, Farsky SH (2013) Chemical synthesis, docking studies and biological effects of a pan peroxisome proliferator-activated receptor agonist and cyclooxygenase inhibitor. Eur J Pharm Sci 48(4):689\u2013697","journal-title":"Eur J Pharm Sci"},{"issue":"11","key":"9815_CR46","doi-asserted-by":"crossref","first-page":"4252","DOI":"10.1021\/jm400446b","volume":"56","author":"R Schwarz","year":"2013","unstructured":"Schwarz R, Tanzler D, Ihling CH, Muller MQ, Kolbel K, Sinz A (2013) Monitoring conformational changes in peroxisome proliferator-activated receptor $$\\alpha$$ \u03b1 by a genetically encoded photoamino acid, cross-linking, and mass spectrometry. J Med Chem 56(11):4252\u20134263","journal-title":"J Med Chem"},{"issue":"2","key":"9815_CR47","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1023\/A:1008100132405","volume":"14","author":"AN Jain","year":"2000","unstructured":"Jain AN (2000) Morphological similarity: a 3D molecular similarity method correlated with protein\u2013ligand recognition. J Comput Aided Mol Des 14(2):199\u2013213","journal-title":"J Comput Aided Mol Des"},{"issue":"4","key":"9815_CR48","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1021\/jm020406h","volume":"46","author":"AN Jain","year":"2003","unstructured":"Jain AN (2003) Surflex: fully automatic flexible molecular docking using a molecular similarity-based search engine. J Med Chem 46(4):499\u2013511","journal-title":"J Med Chem"},{"issue":"7","key":"9815_CR49","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1177\/1087057108321145","volume":"13","author":"ER Goedken","year":"2008","unstructured":"Goedken ER, Gagnon AI, Overmeyer GT, Liu J, Petrillo RA, Burchat AF, Tomlinson MJ (2008) HTRF-based assay for microsomal prostaglandin E2 synthase-1 activity. J Biomol Screen 13(7):619\u2013625","journal-title":"J Biomol Screen"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-014-9815-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10822-014-9815-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-014-9815-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T22:23:06Z","timestamp":1747174986000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10822-014-9815-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,27]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["9815"],"URL":"https:\/\/doi.org\/10.1007\/s10822-014-9815-2","relation":{},"ISSN":["0920-654X","1573-4951"],"issn-type":[{"value":"0920-654X","type":"print"},{"value":"1573-4951","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,27]]}}}